FTC Files Amicus Brief to Protect Consumers from Pharmaceutical Monopolies (opens in new tab)
The Federal Trade Commission filed an amicus brief in an antitrust case alleging that drug manufacturer Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct. The FTC’s brief seeks to protect American consumers from anticompetitive harm by asserting that longstanding Supreme Court precedent has clearly and consistently held that antitrust law is focused on the impact of anticompetitive conduct, not on the intent to harm competition.CareFirst of Maryland Inc. brough...
Read the original article